Completed

Translational research on cancer epigenetics

The purpose is translational research that will result in better patient treatment in cancer.

The expected outcome of the call is to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.

Support to enterprises will be in accordance with the state aid rules.

Website: https://transcan.eu/funding/calls/joint-call-jtc-2023-.kl

Messages at time of print 1 March 2024, 09:22 CET

Important message

For the application deadline 6 March, we manage our hotline +47 22 03 72 00 from Thursday 29 February till Tuesday 5 March at CET 08.00–15.45 and Wednesday 6 March at CET 08.00-13.00.